Global Smart Pills Market Size By Target Area (Targeted Drug Delivery, Vital Sign Monitoring), By Application (Large Intestine, Stomach), By End-User (Hospitals, Diagnostic Centers), By Geographic Scope And Forecast
스마트 필 시장 규모 및 예측
스마트 필 시장 규모는 2024년 59억 5,000만 달러로 평가되며, 2026년부터 2032년까지 CAGR 12.8%로 성장하여 2032년에는 143억 2,000만 달러에 달할 것으로 예상됩니다.
- 스마트 필은 센서, 카메라, 약물전달 시스템을 포함한 섭취 가능한 전자기기입니다. 체내 기능을 모니터링하고 실시간 건강 정보를 수집합니다. 이 알약은 진단, 모니터링, 환자 치료를 개선하는 맞춤형 약물 분배에 사용됩니다.
- 스마트 필은 일반적으로 위장 문제 진단, 복약 순응도 추적, 환자 데이터 수집에 사용됩니다. 스마트 필은 비침습적 대안을 제공하여 표준 의료 절차의 필요성을 줄입니다. 이 기술은 치료의 정확성을 높이고 임상의가 환자 치료에 대한 보다 정확한 판단을 내릴 수 있도록 돕습니다.
- 앞으로 스마트 필은 AI를 활용하여 예측 진단과 맞춤 치료를 개선할 것으로 보입니다. 그 활용은 만성질환 관리를 포함한 다양한 의료 분야로 확대되어 더 나은 의료 결과와 환자 만족도를 가져다 줄 것으로 예상됩니다.
스마트 필 세계 시장 역학
세계 스마트 필 시장을 형성하는 주요 시장 역학은 다음과 같습니다:
주요 시장 촉진요인
- 만성질환의 유병률 증가 : 당뇨병, 심혈관질환 등 만성질환의 유병률 증가는 새로운 건강 솔루션의 필요성을 강조하고 있습니다. 만성질환은 2030년까지 전 세계 사망자의 73%를 차지할 것으로 예상되며, 의료진은 더 나은 질병 관리와 원격 환자 모니터링을 위해 스마트 태블릿을 도입할 것을 촉구하고 있습니다.
- 센서 기술의 발전 : 소형화된 센서와 연결 모듈의 개발로 다양한 생리적 데이터를 모니터링할 수 있는 첨단 스마트 필이 개발되고 있습니다. 세계 스마트 필 시장은 2021년부터 2026년까지 연평균 8.3%의 CAGR로 성장할 것으로 예상되는데, 이는 주로 센서 기술의 발전에 기인합니다.
주요 과제
- 데이터 프라이버시 문제 : 건강 데이터를 추적하기 위한 스마트 필의 사용은 프라이버시 문제를 야기합니다. 환자의 기밀 정보가 유출되거나 해킹되거나 악용될 수 있습니다. 강력한 데이터 보안 조치를 보장하고 HIPAA와 같은 표준을 준수하는 것은 환자의 신뢰를 유지하고 이 기술을 대중화하기 위해 필수적입니다.
- 높은 비용 : 스마트 태블릿과 관련 기술은 설계 및 제조 비용이 비싸기 때문에 사용이 제한적일 수 있습니다. 이러한 높은 비용은 특히 저소득 지역의 의료 시스템 및 개인에게 부담이 되어 보편적 도입과 공평한 기술 접근을 가로막는 큰 장벽이 될 수 있습니다.
- 규제 장애물 : 스마트 태블릿의 승인 절차는 복잡하고, FDA와 같은 규제 기관의 철저한 안전성 및 유효성 평가가 필요합니다. 이러한 규제 프레임워크를 잘 활용하려면 시간이 오래 걸리고 비용이 많이 들 수 있습니다.
주요 동향:
- AI와 머신러닝의 통합 : 스마트 필에 AI와 머신러닝을 사용하면 데이터 처리 능력이 향상되어 더 나은 건강 결과를 얻기 위한 맞춤형 치료와 예측 분석이 가능해집니다.
- 예방 건강 관리의 중요성 : 예방 건강 관리의 중요성이 점점 더 커지고 있으며, 스마트 태블릿은 건강 매개 변수를 모니터링하고 의료 비용을 줄이기 위해 예방적 질병 관리를 촉진하는 데 중요한 역할을 할 수 있습니다.
- 원격의료의 채택 : 원격의료의 활용은 원격 모니터링과 환자와 의료진의 접촉을 가능하게함으로써 의료에 대한 접근과 환자 참여를 촉진하고, 스마트 필의 수요를 높이고 있습니다.
목차
제1장 스마트 필 세계 시장 소개
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH 조사 방법
- 데이터 마이닝
- 검증
- 1차 자료
- 데이터 소스 리스트
- 시장 매력
제4장 스마트 필 세계 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
제5장 스마트 필 세계 시장 : 용도별
- 개요
- 캡슐 내시경
- 표적 약물전달
- 바이탈 사인 모니터링
제6장 스마트 필 세계 시장 : 대상 영역별
제7장 스마트 필 세계 시장 : 최종사용자별
제8장 스마트 필 세계 시장 : 지역별
제9장 세계의 스마트 필 시장 경쟁 구도
- 개요
- 각사의 시장 순위
- 주요 개발 전략
- ACE 매트릭스
제10장 기업 개요
- GE Healthcare
- Boston Scientific Corporation
- Given Imaging, Inc.
- Olympus Corporation
- BioImages Research Ltd.
- Medimetrics S.A. DE C.V
- Karl Storz Gmbh & Co. KG
- Fujifilm Holdings Corporation
- Cerner Corporation
- Proteus Digital Health, Inc.
제11장 주요 발전
- 제품 출시/개발
- 인수합병
- 사업 확대
- 파트너십과 제휴
제12장 부록
ksm
Smart Pills Market Size And Forecast
Smart Pills Market size was valued at USD 5.95 Billion in 2024 and is projected to reach USD 14.32 Billion by 2032 growing at a CAGR of 12.8% from 2026 to 2032.
- Smart pills are ingestible electronic devices that include sensors, cameras, and medicine delivery systems. They monitor internal bodily functions and collect real-time health information. These pills are used for diagnostics, monitoring, and tailored drug distribution, which improves patient care.
- Smart pills are generally used to diagnose gastrointestinal issues, track drug adherence, and collect patient data. They offer non-invasive alternatives, which reduce the need for standard medical procedures. This technology enhances treatment accuracy and enables clinicians to make better judgments about patient care.
- In the future, smart medicines will use AI to improve predictive diagnosis and individualized therapy. Their use is predicted to grow in a variety of medical sectors, including chronic disease management, resulting in better healthcare results and patient satisfaction.
Global Smart Pills Market Dynamics
The key market dynamics that are shaping the global smart pills market include:
Key Market Drivers:
- Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, highlights the need for novel health solutions. Chronic diseases are expected to account for 73% of global fatalities by 2030, prompting healthcare practitioners to implement smart tablets for better disease management and remote patient monitoring.
- Advancements In Sensor Technology: Advancements in miniaturized sensors and connectivity modules have resulted in the development of advanced smart pills capable of monitoring a variety of physiological data. The global smart pill market is expected to develop at an 8.3% CAGR between 2021 and 2026, owing mostly to advancements in sensor technology.
Key Challenges:
- Data Privacy Concerns: The usage of smart pills to track health data poses privacy issues. Sensitive patient information may be compromised, hacked, or misused. Ensuring strong data security measures and obeying to standards such as HIPAA are critical to sustaining patient trust and widespread use of this technology.
- High Costs: Smart tablets and their accompanying technologies can be costly to design and manufacture, restricting availability. This high cost can also burden healthcare systems and individuals, especially in low-income areas, creating a significant barrier to universal adoption and fair access to technology.
- Regulatory Hurdles: The clearance procedure for smart tablets is complex, requiring thorough safety and efficacy assessments by regulatory agencies such as the FDA. Navigating these regulatory frameworks can be time-consuming and potentially costly.
Key Trends:
- Integration Of AI And Machine Learning: The use of AI and machine learning in smart pills improves data processing capabilities, allowing for tailored treatment and predictive analytics for better health results.
- Focus On Preventive Healthcare: Preventive healthcare is becoming increasingly important, with smart tablets playing a critical role in monitoring health parameters and promoting proactive illness management to decrease healthcare expenditures.
- Telemedicine Adoption: Telemedicine usage is boosting demand for smart pills, which allow for remote monitoring and patient-provider contact, thereby enhancing access to care and patient participation.
Global Smart Pills Market Regional Analysis
Here is a more detailed regional analysis of the global smart pills market:
North America:
- According to Verified Market Research, North America is expected to dominate the global smart pills market.
- The high frequency of gastrointestinal illnesses in North America promotes the use of smart tablets for diagnosis and therapy. The National Institute of Diabetes and Digestive and Kidney illnesses (NIDDK) estimates that 60 to 70 million Americans suffer from digestive illnesses. This prevalent incidence drives up the need for smart pills as a diagnostic tool.
- North America's advanced healthcare infrastructure and large healthcare expenditures all contribute to the adoption of smart pills. With U.S. healthcare spending expected to exceed USD 4.1 Trillion by 2020, the region's developed healthcare system promotes the integration of cutting-edge medical technology such as smart pills, hence improving patient care.
Asia Pacific:
- According to Verified Market Research, Asia Pacific is fastest growing region in global smart pills market.
- The increasing prevalence of gastrointestinal illnesses in Asia Pacific is pushing the demand for smart pills. Research published in the Journal of Gastroenterology and Hepatology suggests that the prevalence of gastrointestinal problems in the region ranges from 5.5% to 34.2%.
- In China, approximately 5-6% of the population suffers with irritable bowel syndrome, affecting 70-80 million people. These numbers indicate the increased healthcare needs for digestive health. As traditional techniques of diagnosis and management have limits, smart tablets provide a more advanced, non-invasive approach, making them an appealing choice for improving patient outcomes in gastrointestinal healthcare.
Global Smart Pills Market: Segmentation Analysis
The Global Smart Pills Market is segmented based Target Area, Application, End-User, and Geography.
Smart Pills Market, By Target Area
- Esophagus
- Small Intestine
- Large Intestine
- Stomach
Based on Target Area, the Global Smart Pills Market is separated into Esophagus, Small Intestine, Large Intestine, and Stomach. In the global smart pill market, the small intestine segment dominates. This is primarily due to its vital function in nutrient absorption and the growing necessity to monitor gastrointestinal illnesses. Smart tablets created for the small intestine allow for accurate detection and treatment of illnesses such as Crohn's disease and celiac disease.
Smart Pills Market, By Application
- Capsule Endoscopy
- Targeted Drug Delivery
- Vital Sign Monitoring
Based on Application, Global Smart Pills Market is divided into Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring. Capsule endoscopy is now the most popular use for smart pills worldwide. This approach allows for non-invasive imaging of the gastrointestinal tract, which provides important diagnostic information. The rising prevalence of gastrointestinal illnesses, as well as the demand for effective diagnostic tools, propel it to market leadership, improving patient comfort and procedural efficiency.
Smart Pills Market, By End-User
- Hospitals
- Diagnostic Centers
Based on End-User, Global Smart Pills Market is divided into Hospitals and Diagnostic Centers. Hospitals dominate the global smart pill market because of their complete healthcare services, improved technological integration and greater use of remote monitoring systems, which improve patient care and treatment outcomes.
Key Players
- The Global Smart Pills Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are GE Healthcare, Boston Scientific Corporation, Given Imaging, Inc., Olympus Corporation, BioImages Research Ltd., Medimetrics S.A. DE C.V, Karl Storz Gmbh & Co. KG, Fujifilm Holdings Corporation, Cerner Corporation, Proteus Digital Health, Inc.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
- Global Smart Pills Market Recent Developments
- In January 2019, Proteus Digital Health delivered its first digital cancer chemotherapy tablet to aid clinicians in tracking treatment success and adherence among cancer patients.
- In August 2020, Otsuka paid USD 15 million for Proteus Digital Health, a manufacturer of smart pills.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL SMART PILLS MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
- 3.5 Market attractiveness
4 GLOBAL SMART PILLS MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
5 GLOBAL SMART PILLS MARKET, BY APPLICATION
- 5.1 Overview
- 5.2 Capsule Endoscopy
- 5.3 Targeted Drug Delivery
- 5.4 Vital Sign Monitoring
6 GLOBAL SMART PILLS MARKET, BY TARGET AREA
- 6.1 Overview
- 6.2 Esophagus
- 6.3 Small Intestine
- 6.4 Large Intestine
- 6.5 Stomach
7 GLOBAL SMART PILLS MARKET, BY END USER
- 7.1 Overview
- 7.2 Hospitals
- 7.3 Diagnostic Centers
8 GLOBAL SMART PILLS MARKET, BY GEOGRAPHY
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
- 8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa
9 GLOBAL SMART PILLS MARKET COMPETITIVE LANDSCAPE
- 9.1 Overview
- 9.2 Company Market Ranking
- 9.3 Key Development Strategies
- 9.4 ACE Matrix
10 COMPANY PROFILES
- 10.1 GE Healthcare
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Boston Scientific Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Given Imaging, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 Olympus Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 BioImages Research Ltd.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 Medimetrics S.A. DE C.V
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Karl Storz Gmbh & Co. KG
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 Fujifilm Holdings Corporation
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 Cerner Corporation
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 10.10 Proteus Digital Health, Inc.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
11 KEY DEVELOPMENTS
- 11.1 Product Launches/Developments
- 11.2 Mergers and Acquisitions
- 11.3 Business Expansions
- 11.4 Partnerships and Collaborations
12 Appendix
